AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
226.82
+4.00 (1.80%)
Dec 19, 2025, 4:00 PM EST - Market closed
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
$1,084,436
Profits / Employee
$42,691
Market Cap
400.88B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
| Jan 31, 2024 | 50,000 | 0 | - |
| Jan 31, 2023 | 50,000 | 0 | - |
| Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
| Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
| Jan 31, 2020 | 30,000 | 0 | - |
| Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
| Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
| Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
| Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
| Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
| Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
| Jan 31, 2013 | 21,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABBV News
- 1 day ago - Trump to announce new drug-pricing deals later today - Market Watch
- 3 days ago - AbbVie, several other pharma companies near MFN deal with Trump, sources say - Reuters
- 6 days ago - AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings - Seeking Alpha
- 10 days ago - AbbVie: Unique Mix Of Growth And Value - Seeking Alpha
- 13 days ago - OSE Immunotherapeutics Announces Strategic Amendment to AbbVie's Partnership on ABBV-230 Development - GlobeNewsWire
- 17 days ago - AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 18 days ago - AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers - PRNewsWire
- 20 days ago - AbbVie: Increased Outlook For 2025 And Expansions Merit Continued "Strong Buy" Rating - Seeking Alpha